Is the Aussie property market ready for a fall? The experts seem to think so. One thing to remember in all this is that the experts have been predicting an Aussie property crash every year now since 2011.
When thinking about your longer-term strategy, the first question you should ask is, are we in a bull or bear market? At the start of the year, I was pretty confident we were in an ongoing bull market. Now I’m not so sure.
Caterpillar [NYSE:CAT] shares are up 55% for the year. Being so big, and having operations so wide, it’s the perfect bellwether stock to see how the global economy is ticking over.
With a market cap of over $5 billion, A2M is one of the largest listed infant formula and milk companies. Could smaller competitor Wattle Health Australia Ltd [ASX:WHA] experience the same success?
Given the headwinds facing gold, it’s held up surprisingly well. The bitcoin phenomenon, bullish equity markets, a strong economy and rising interest rates are all traditionally negative for gold. Gold has had a pretty good year, considering. It’s trending higher and I think there is a good chance of it taking another leg up sooner rather than later.
Canada is now one step closer to legalising weed. Today, the House of Commons has passed bill C-45, the bill that’s set to make marijuana legal in the country.
While it might be too early to jump in and thumb your nose at the Amazon effect. Keep an eye out for turning points like the above. That is, when you see buying on negative news. It means the news wasn’t as bad as expected. Often this is a turning point.
Amazon is set to take over the retail and logistics world in Australia. Whoever recycles and supplies cardboard boxes must be ready to mint a small fortune.
ASX 200 looks to have just experienced a ‘false break of the high’. The question is, just how bearish is it? Why worry about the market anyway? It’s only an index. That’s true. But getting the overall movement of the market right allows you to position your portfolio for maximum gains.
Biotechnology relies on data to conduct research. It’s the key ingredient in the validation process. Big data is not new. But what is new is the addition of blockchain to big data. It’s an intersection of big data, blockchain and biotech. And if it plays out as I think it will, biotech valuations will surge big time.